Paladin in distribution pact with BTG
February 25, 2010 by leonardzehr · Leave a Comment
Paladin Labs (TSX:PLB) has entered into a distribution agreement with Protherics, a unit of BTG PLC, for the exclusive Canadian rights to market and sell DigiFab, which is under Health Canada review to treat life-threatening or potentially life-threatening digoxin toxicity or overdose. “DigiFab provides an important opportunity to grow Paladin’s specialty and orphan franchise, which [...]
Listen to BioTuesdays 
